Avecho Biotechnology Limited (ASX:AVE)
Australia
· Delayed Price · Currency is AUD 0.0110
-0.0010 (-8.33%)
Mar 10, 2026, 2:38 PM AEST
Avecho Biotechnology Balance Sheet
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 4.66 | 2.37 | 5.5 | 1.47 | 3.26 | Upgrade
|
| Cash & Short-Term Investments | 4.66 | 2.37 | 5.5 | 1.47 | 3.26 | Upgrade
|
| Cash Growth | 96.40% | -56.86% | 274.90% | -55.03% | 74.33% | Upgrade
|
| Accounts Receivable | 0.16 | 0.57 | - | - | 0.04 | Upgrade
|
| Other Receivables | 2.05 | 1.68 | 1.1 | 0.75 | 1.09 | Upgrade
|
| Receivables | 2.2 | 2.25 | 1.1 | 0.75 | 1.13 | Upgrade
|
| Inventory | 0.01 | 0.14 | 0.1 | 0.4 | 0.2 | Upgrade
|
| Prepaid Expenses | - | - | - | 0.23 | 0.22 | Upgrade
|
| Other Current Assets | 0.18 | 0.05 | 0.3 | 0.01 | - | Upgrade
|
| Total Current Assets | 7.06 | 4.81 | 7 | 2.85 | 4.81 | Upgrade
|
| Property, Plant & Equipment | 0.03 | 0.17 | 0.32 | 0.47 | 0.34 | Upgrade
|
| Other Intangible Assets | - | - | - | 0.03 | 0.1 | Upgrade
|
| Other Long-Term Assets | 0.02 | 0.02 | - | - | - | Upgrade
|
| Total Assets | 7.11 | 5 | 7.32 | 3.35 | 5.25 | Upgrade
|
| Accounts Payable | 0.1 | 0.06 | 0.09 | 0.19 | 0.08 | Upgrade
|
| Accrued Expenses | 0.56 | 0.56 | 0.49 | 0.46 | 0.42 | Upgrade
|
| Short-Term Debt | - | 0.98 | - | - | - | Upgrade
|
| Current Portion of Leases | 0.01 | 0.08 | 0.08 | 0.07 | 0.08 | Upgrade
|
| Current Unearned Revenue | - | - | 0.16 | - | - | Upgrade
|
| Other Current Liabilities | 0.03 | 0.02 | 0.02 | 0.02 | 0.12 | Upgrade
|
| Total Current Liabilities | 0.71 | 1.71 | 0.84 | 0.75 | 0.7 | Upgrade
|
| Long-Term Leases | - | 0.01 | 0.1 | 0.18 | 0.01 | Upgrade
|
| Long-Term Unearned Revenue | 4.83 | - | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 0 | 0 | - | - | - | Upgrade
|
| Total Liabilities | 5.55 | 1.73 | 0.94 | 0.92 | 0.71 | Upgrade
|
| Common Stock | 246.9 | 244.61 | 244.61 | 237.53 | 237.6 | Upgrade
|
| Retained Earnings | -273.81 | -269.39 | -267.44 | -264.1 | -262.07 | Upgrade
|
| Comprehensive Income & Other | 28.47 | 28.06 | 29.21 | 29 | 29 | Upgrade
|
| Shareholders' Equity | 1.56 | 3.27 | 6.38 | 2.42 | 4.54 | Upgrade
|
| Total Liabilities & Equity | 7.11 | 5 | 7.32 | 3.35 | 5.25 | Upgrade
|
| Total Debt | 0.01 | 1.08 | 0.18 | 0.25 | 0.09 | Upgrade
|
| Net Cash (Debt) | 4.65 | 1.3 | 5.33 | 1.22 | 3.17 | Upgrade
|
| Net Cash Growth | 258.21% | -75.65% | 336.06% | -61.46% | 85.80% | Upgrade
|
| Net Cash Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
| Filing Date Shares Outstanding | 3,673 | 3,169 | 3,169 | 1,838 | 1,838 | Upgrade
|
| Total Common Shares Outstanding | 3,673 | 3,169 | 3,169 | 1,838 | 1,836 | Upgrade
|
| Working Capital | 6.35 | 3.1 | 6.16 | 2.11 | 4.11 | Upgrade
|
| Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
| Tangible Book Value | 1.56 | 3.27 | 6.38 | 2.4 | 4.43 | Upgrade
|
| Tangible Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
| Machinery | - | - | - | - | 0.55 | Upgrade
|
| Leasehold Improvements | - | - | - | - | 0.2 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.